Please assess the completion status of the following clinical trial:

Trial Title: Post Market Clinical Follow-Up Study Protocol for PROFEMUR® Gladiator Cemented Femoral Stems

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: COHORT
- Primary Purpose: None
- Time Perspective: PROSPECTIVE
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Has undergone primary THA for any of the following:~* Non-inflammatory degenerative joint disease such as osteoarthritis, avascular necrosis, ankylosis, protrusio acetabuli, or painful hip dysplasia;~* Inflammatory degenerative joint disease such as rheumatoid arthritis; or~* Correction of functional deformity~* Subject is implanted with the specified combination of components~* Subject is willing and able to complete required study visits or assessments~Exclusion Criteria:~* Subjects implanted with a metal-on-metal articulation~* Subjects implanted with non-MPO or non-Wright Medical Technology components (femoral heads, acetabular shells, acetabular liners) in the enrolled THA~* Subjects skeletally immature (less than 21 years of age) at time of primary THA surgery~* Subjects currently enrolled in another clinical study which could affect the endpoints of this protocol~* Subjects unwilling to sign the Informed Consent document~* Subjects with substance abuse issues~* Subjects who are incarcerated or have pending incarceration

- Gender: ALL
- Minimum Age: 21 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Total Hip Arthroplasty (Type: None): Single group previously implanted with the following combination of components: PROFEMUR® Gladiator femoral stem, MicroPort acetabular shell, MicroPort Orthopedics polyethylene or ceramic liner, MicroPort Orthopedics metal or ceramic femoral head.

Based on this trial design, predict the completion outcome and termination type (if applicable).